ergoline and Hearing-Loss

Ischemia and the metabolic disorder it entails would seem to be the pathogenic mechanism behind acute cochlear deafness, irrespective of the triggering process. The prognosis is entirely dependent on the rapid initiation of an effective treatment. At the end of a double-blind therapeutic trial comparing Ginkgo biloba extract and a standard alpha blocker (nicergoline), a significant recovery was observed in both therapeutic groups, but improvement was distinctly better in the Ginkgo biloba group.

Topics: Audiometry, Pure-Tone; Audiometry, Speech; Clinical Trials as Topic; Cochlea; Ergolines; Hearing Loss; Hearing Loss, Conductive; Humans; Ischemia; Middle Aged; Nicergoline; Plant Extracts; Plants, Medicinal; Random Allocation; Trees